- Report
- January 2022
- 40 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Japan
From €1426EUR$1,500USD£1,198GBP
The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases.
The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market.
Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more